Kristina Wallenius

2.7k total citations · 1 hit paper
37 papers, 2.2k citations indexed

About

Kristina Wallenius is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Physiology. According to data from OpenAlex, Kristina Wallenius has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Epidemiology and 13 papers in Physiology. Recurrent topics in Kristina Wallenius's work include Adipose Tissue and Metabolism (9 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Pancreatic function and diabetes (9 papers). Kristina Wallenius is often cited by papers focused on Adipose Tissue and Metabolism (9 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Pancreatic function and diabetes (9 papers). Kristina Wallenius collaborates with scholars based in Sweden, United States and United Kingdom. Kristina Wallenius's co-authors include John‐Olov Jansson, Ville Wallenius, Suzanne L. Dickson, Claes Ohlsson, Bo Åhrén, Hans Carlsten, Mats Rudling, Ingrid Wernstedt Asterholm, David Sunter and Olle Isaksson and has published in prestigious journals such as Nature Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Kristina Wallenius

34 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-6-deficient mice develop mature-onset obesity

2002 987 citations Ville Wallenius, Kristina Wallenius et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristina Wallenius Sweden	19	989	919	582	455	443	37	2.2k
Heikki A. Koistinen Finland	29	1.3k 1.3×	743 0.8×	1.2k 2.0×	560 1.2×	371 0.8×	57	2.8k
Marek Strączkowski Poland	26	927 0.9×	815 0.9×	827 1.4×	288 0.6×	355 0.8×	76	2.4k
Kristin Eckardt Germany	29	1.7k 1.7×	1.0k 1.1×	1.1k 1.8×	229 0.5×	521 1.2×	41	3.4k
Mary Erickson United States	9	1.0k 1.0×	1.5k 1.6×	455 0.8×	479 1.1×	320 0.7×	13	2.0k
Mengliu Yang China	30	767 0.8×	802 0.9×	933 1.6×	306 0.7×	488 1.1×	94	2.5k
Hye Lim Noh United States	26	1.1k 1.1×	839 0.9×	1.2k 2.1×	176 0.4×	445 1.0×	40	2.8k
Florian W. Kiefer Austria	25	1.2k 1.2×	854 0.9×	653 1.1×	119 0.3×	352 0.8×	60	2.5k
Xingxing Kong China	20	1.6k 1.6×	897 1.0×	971 1.7×	378 0.8×	112 0.3×	48	2.8k
Ruby L.C. Hoo Hong Kong	28	1.1k 1.1×	1.3k 1.4×	1.4k 2.3×	290 0.6×	395 0.9×	50	3.5k
Todd Schraw United States	13	1.2k 1.2×	1.3k 1.4×	650 1.1×	320 0.7×	274 0.6×	16	2.4k

Countries citing papers authored by Kristina Wallenius

Since Specialization

Citations

This map shows the geographic impact of Kristina Wallenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Wallenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Wallenius more than expected).

Fields of papers citing papers by Kristina Wallenius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Wallenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Wallenius. The network helps show where Kristina Wallenius may publish in the future.

Co-authorship network of co-authors of Kristina Wallenius

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Wallenius. A scholar is included among the top collaborators of Kristina Wallenius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Wallenius. Kristina Wallenius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chung, Heaseung Sophia, Manik Garg, Ventzislava A. Hristova, et al.. (2024). Longitudinal clinical and proteomic diabetes signatures in women with a history of postgestational diabetes. JCI Insight. 10(2).

Park, Sehyung, Lindsey R. Conroy, Harrison A. Clarke, et al.. (2024). Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism. JCI Insight. 9(23). 5 indexed citations

Andersson‐Hall, Ulrika, et al.. (2024). Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria. Diabetes Research and Clinical Practice. 216. 111831–111831.

Liu, Cong, Milena Schönke, Joost M. Lambooij, et al.. (2023). FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis. eLife. 12. 46 indexed citations

Alexandersson, Ida, Stefanie Maurer, Bader Zarrouki, et al.. (2022). Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats. Science Translational Medicine. 14(668). eabh1316–eabh1316. 9 indexed citations

Wallenius, Kristina, Lars Löfgren, Maria Sörhede‐Winzell, et al.. (2022). The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis. Journal of Lipid Research. 63(3). 100176–100176. 48 indexed citations

Park, Sehyung, Robert N. Helsley, Leila Noetzli, et al.. (2021). A luminescence-based protocol for assessing fructose metabolism via quantification of ketohexokinase enzymatic activity in mouse or human hepatocytes. STAR Protocols. 2(3). 100731–100731. 5 indexed citations

Kjellstedt, Ann, Anna Lindblom, Lars Löfgren, et al.. (2019). 1881-P: The SGLT2 Inhibitor Dapagliflozin Improves Glucose Control and Enhances Liver Fatty Acid Oxidation and Ketone Body Formation in Insulin Resistant Obese Zucker Rats. Diabetes. 68(Supplement_1). 1 indexed citations

Wallenius, Kristina, Pia Thalén, Jan‐Arne Björkman, et al.. (2017). Involvement of the metabolic sensor GPR81 in cardiovascular control. JCI Insight. 2(19). 43 indexed citations

10.

Admyre, Therése, Martin Bauer, Mikael Bjursell, et al.. (2014). Inhibition of AMP Deaminase Activity Does Not Improve Glucose Control in Rodent Models of Insulin Resistance or Diabetes. Chemistry & Biology. 21(11). 1486–1496. 20 indexed citations

11.

Wallenius, Kristina, Ann Kjellstedt, Pia Thalén, Lars Löfgren, & Nicholas D. Oakes. (2013). The PPARα/γAgonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid UtilizationIn Vivoin the Obese Zucker Rat. PPAR Research. 2013. 1–14. 20 indexed citations

12.

Gabrielsson, Johan, et al.. (2009). Turnover Modeling of Non-Esterified Fatty Acids in Rats after Multiple Intravenous Infusions of Nicotinic Acid. Dose-Response. 7(3). 247–69. 15 indexed citations

13.

Wallenius, Kristina, John‐Olov Jansson, & Ville Wallenius. (2003). The therapeutic potential of interleukin-6 in treating obesity. Expert Opinion on Biological Therapy. 3(7). 1061–1070. 32 indexed citations

14.

Stenlöf, Kaj, et al.. (2003). Interleukin-6 Levels in the Central Nervous System Are Negatively Correlated with Fat Mass in Overweight/Obese Subjects. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4379–4383. 119 indexed citations

15.

Wallenius, Kristina, Ville Wallenius, David Sunter, Suzanne L. Dickson, & John‐Olov Jansson. (2002). Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochemical and Biophysical Research Communications. 293(1). 560–565. 194 indexed citations

16.

Wallenius, Ville, Kristina Wallenius, Bo Åhrén, et al.. (2002). Interleukin-6-deficient mice develop mature-onset obesity. Nature Medicine. 8(1). 75–79. 987 indexed citations breakdown →

17.

Wallenius, Ville, Kristina Wallenius, Masanori Hisaoka, et al.. (2001). Retarded Liver Growth in Interleukin-6-Deficient and Tumor Necrosis Factor Receptor-1-Deficient Mice*. Endocrinology. 142(7). 2953–2960. 18 indexed citations

18.

Skrtic, Stanko, Kristina Wallenius, Klara Sjögren, et al.. (2001). Possible Roles of Insulin-Like Growth Factor in Regulation of Physiological and Pathophysiological Liver Growth. Hormone Research in Paediatrics. 55(Suppl. 1). 1–6. 9 indexed citations

19.

Skrtic, Stanko, Kristina Wallenius, A Gressner, & John‐Olov Jansson. (2000). Insulin-like growth factor signaling pathways in rat hepatic stellate cells: Importance for DNA synthesis and hepatocyte growth factor production. Journal of Hepatology. 32. 84–84. 1 indexed citations

20.

Wallenius, Ville, Kristina Wallenius, & John‐Olov Jansson. (2000). Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6−/−) mice. Journal of Hepatology. 33(6). 967–974. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact